Quanglong N. Truong

Array ( [id] => 19845081 [patent_doc_number] => 20250090432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => Oral Care Compositions [patent_app_type] => utility [patent_app_number] => 18/884323 [patent_app_country] => US [patent_app_date] => 2024-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18884323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19656840 [patent_doc_number] => 20240423905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => N-ACETYLCYSTEINE COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/830389 [patent_app_country] => US [patent_app_date] => 2024-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18830389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19870414 [patent_doc_number] => 12263253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-01 [patent_title] => Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/816200 [patent_app_country] => US [patent_app_date] => 2024-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 33 [patent_no_of_words] => 21961 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18816200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19845366 [patent_doc_number] => 20250090717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => THERAPEUTIC USE OF FIBROBLASTS FOR ADHESIVE BANDAGE WOUND HEALING [patent_app_type] => utility [patent_app_number] => 18/808529 [patent_app_country] => US [patent_app_date] => 2024-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19613022 [patent_doc_number] => 20240398702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => DEVICES AND METHODS FOR DELIVERING METHANE INHIBITING COMPOUNDS TO ANIMALS [patent_app_type] => utility [patent_app_number] => 18/804622 [patent_app_country] => US [patent_app_date] => 2024-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44535 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18804622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19768260 [patent_doc_number] => 20250049686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => COLLAGEN SERUM FORMULATIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/802534 [patent_app_country] => US [patent_app_date] => 2024-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12004 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18802534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19599388 [patent_doc_number] => 20240390268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => Mycophenolate Oral Suspension [patent_app_type] => utility [patent_app_number] => 18/797717 [patent_app_country] => US [patent_app_date] => 2024-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10467 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18797717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19613020 [patent_doc_number] => 20240398700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => Mycophenolate Oral Suspension [patent_app_type] => utility [patent_app_number] => 18/797696 [patent_app_country] => US [patent_app_date] => 2024-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10495 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18797696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20509935 [patent_doc_number] => 20260034033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-05 [patent_title] => MAKEUP COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/788511 [patent_app_country] => US [patent_app_date] => 2024-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18788511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19845376 [patent_doc_number] => 20250090727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => INTEGRATED BIOMATERIAL SCAFFOLD WITH 3D PRINTED LATTICE BACKBONE [patent_app_type] => utility [patent_app_number] => 18/784881 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19570224 [patent_doc_number] => 20240374516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => READY TO USE ORAL PHARMACEUTICAL SUSPENSION OF DASATINIB [patent_app_type] => utility [patent_app_number] => 18/780566 [patent_app_country] => US [patent_app_date] => 2024-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8188 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18780566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19707708 [patent_doc_number] => 20250017850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => SALBUTAMOL DELIVERY FORMULATIONS, DEVICES AND METHODS [patent_app_type] => utility [patent_app_number] => 18/771332 [patent_app_country] => US [patent_app_date] => 2024-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10392 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18771332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784109 [patent_doc_number] => 20250057788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC PAIN AND DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/736572 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6646 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18736572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20401236 [patent_doc_number] => 12491196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same [patent_app_type] => utility [patent_app_number] => 18/735876 [patent_app_country] => US [patent_app_date] => 2024-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21318 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18735876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20099062 [patent_doc_number] => 20250228998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => Anionic Citrate-Based Biomaterials [patent_app_type] => utility [patent_app_number] => 18/736005 [patent_app_country] => US [patent_app_date] => 2024-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18736005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20005640 [patent_doc_number] => 20250143862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-08 [patent_title] => METHODS AND DEVICES FOR PRE-VASCULARIZATION OF IMPLANTATION SITES AND/OR CELL ENCAPSULATION DEVICES [patent_app_type] => utility [patent_app_number] => 18/735879 [patent_app_country] => US [patent_app_date] => 2024-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19049 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18735879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20401237 [patent_doc_number] => 12491197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same [patent_app_type] => utility [patent_app_number] => 18/735889 [patent_app_country] => US [patent_app_date] => 2024-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21178 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18735889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19496449 [patent_doc_number] => 20240335467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE [patent_app_type] => utility [patent_app_number] => 18/735463 [patent_app_country] => US [patent_app_date] => 2024-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29388 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18735463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20401235 [patent_doc_number] => 12491195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Concentrated liquid pharmaceutical Formulations of furosemide and methods of administering the same [patent_app_type] => utility [patent_app_number] => 18/671025 [patent_app_country] => US [patent_app_date] => 2024-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21403 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18671025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20401234 [patent_doc_number] => 12491194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same [patent_app_type] => utility [patent_app_number] => 18/667326 [patent_app_country] => US [patent_app_date] => 2024-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21309 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18667326 [rel_patent_id] =>[rel_patent_doc_number] =>)